SCHEMBL14467196

SCHEMBL14467196

O=C1NC(=O)[C@H](c2cc3ncccc3[nH]2)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.48
▸ ATAD2 Q6PL18 1/20 0.48
▸ CNR2 P34972 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.37
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GSK3B P49841 1/20 0.34
▸ SNCA P37840 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ RBP4 P02753 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ DRD3 P35462 2/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11667144 0.77 HDAC8 (0.42) DAOCNR2TDP1MAPT
SCHEMBL31212677 0.74 KDM5A (0.48) DAOATAD2CNR2HRH4MAPT
SCHEMBL9828753 0.72 POLB (0.47) DAOTDP1MAPTALDH1A1GAA
SCHEMBL7943370 0.71 CHRNB2 (0.56) TDP1MAPTALDH1A1GSK3BGAA
SCHEMBL13363233 0.71 TDP1 (0.40) TDP1MAPTALDH1A1GSK3BGAA
SCHEMBL28744550 0.70 CCNT1 (0.44) DAOATAD2
SCHEMBL23745244 0.68 DDB1 (0.51) TDP1MAPTALDH1A1GSK3BGAA
SCHEMBL2563428 0.68 DDB1 (0.51) TDP1MAPTALDH1A1GSK3BGAA
SCHEMBL20284764 0.68 DRD2 (0.43) DRD3DRD2
SCHEMBL2005757 0.68 CCNK (0.44) DAOATAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976849-B1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2016-03-09 — — EP disclosed
WO-2007084415-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 — — WO disclosed
Send feedback